Insights+

EMA Marketing Authorization of New Drugs in December 2024

EMA Marketing Authorization of New Drugs in December 2024

Shots:    The EMA’s CHMP has granted positive opinions...

Disease of the Month – Epilepsy

Disease of the Month – Epilepsy

Shots:  Epilepsy is a chronic, non-communicable brain condition that affects...

Know Your Investor: RA Capital Management (January’25 Edition)

Know Your Investor: RA Capital Management (January’25 Edition)

Shots:    The January Edition features RA Capital Management, a glo...

J.P. Morgan Special: Dealmaker of the Year 2024 (Part 02)

J.P. Morgan Special: Dealmaker of the Year 2024 (Part 02)

Shots:   In this second installment of Dealmaker 2024, PharmaShots presents a...

The US FDA New Drug Approvals in December 2024

The US FDA New Drug Approvals in December 2024

Shots:      PharmaShots has compiled a list of US F...

PharmaShots’ Key Highlights of Fourth Quarter 2024

PharmaShots’ Key Highlights of Fourth Quarter 2024

Shots:  The Fourth quarter of 2024 highlights major acquisitions in the...

Image